1-155268012-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001294338.2(CLK2):āc.669G>Cā(p.Lys223Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,610,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001294338.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLK2 | NM_001294338.2 | c.669G>C | p.Lys223Asn | missense_variant, splice_region_variant | 6/13 | ENST00000368361.9 | NP_001281267.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLK2 | ENST00000368361.9 | c.669G>C | p.Lys223Asn | missense_variant, splice_region_variant | 6/13 | 1 | NM_001294338.2 | ENSP00000357345 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251402Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135868
GnomAD4 exome AF: 0.0000247 AC: 36AN: 1458800Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 725956
GnomAD4 genome AF: 0.000250 AC: 38AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.666G>C (p.K222N) alteration is located in exon 6 (coding exon 5) of the CLK2 gene. This alteration results from a G to C substitution at nucleotide position 666, causing the lysine (K) at amino acid position 222 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at